| 000 | 01778 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513185145.0 | ||
| 264 | 0 | _c19990819 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0160-564X | ||
| 024 | 7 |
_a10.1046/j.1525-1594.1999.06401.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNishida, H | |
| 245 | 0 | 0 |
_aComparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. _h[electronic resource] |
| 260 |
_bArtificial organs _cJun 1999 |
||
| 300 |
_a547-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdsorption |
| 650 | 0 | 4 | _aAir |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aBiocompatible Materials _xchemistry |
| 650 | 0 | 4 | _aBlood |
| 650 | 0 | 4 |
_aBlood Proteins _xanalysis |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xinstrumentation |
| 650 | 0 | 4 |
_aCoated Materials, Biocompatible _xchemistry |
| 650 | 0 | 4 |
_aComplement C3a _xanalysis |
| 650 | 0 | 4 |
_aFibrin _xanalysis |
| 650 | 0 | 4 |
_aFibrinogen _xanalysis |
| 650 | 0 | 4 | _aHemodilution |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aOxygenators |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 | _aSurface Properties |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_abeta-Thromboglobulin _xanalysis |
| 700 | 1 | _aAomi, S | |
| 700 | 1 | _aTomizawa, Y | |
| 700 | 1 | _aEndo, M | |
| 700 | 1 | _aKoyanagi, H | |
| 700 | 1 | _aNojiri, C | |
| 700 | 1 | _aOshiyama, H | |
| 700 | 1 | _aKido, T | |
| 700 | 1 | _aYokoyama, K | |
| 773 | 0 |
_tArtificial organs _gvol. 23 _gno. 6 _gp. 547-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1525-1594.1999.06401.x _zAvailable from publisher's website |
| 999 |
_c10350612 _d10350612 |
||